Purpose-built for physicians GLP-1s may reduce cardiovascular risk in rheumatoid arthritis treated with JAK inhibitors GLP-1 receptor agonists may significantly reduce the risk for cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors, according to data presented at the EULAR 2025 Congress
In conclusion, understanding the histopathological features of AA allows for more accurate diagnoses, personalized treatment methods, and a better understanding of the diseases underlying pathophysiology
105 [PMC free article: PMC7067537] [PubMed: 31837264] 243
Aids Muscle Recovery Supports post-workout recovery and reduces muscle soreness
This dual action makes it a powerful tool for managing diabetes and obesity
212 FBXO31 enhances cisplatin-induced ferroptosis in cholangiocarcinoma cells and stem cell-like cells, and the mechanism may be related to increased GPX4 ubiquitination and proteasome degradation, which could be reversed by GPX4 overexpression